Setrusumab
Product Specifications
UNSPSC Description
Setrusumab (BPS 804) is a fully human monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/setrusumab.html
Purity
99.00
Solubility
10 mM in DMSO
Smiles
[Setrusumab]
References & Citations
[1]Hesse E, et al. Sclerostin inhibition alleviates breast cancer-induced bone metastases and muscle weakness. JCI Insight. 2019 Apr 9;5(9):e125543.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99398/Setrusumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99398/Setrusumab-SDS-MedChemExpress.pdf
Clinical Information
Phase 3
CAS Number
1847394-95-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
BNUB1997-100 100 µL
Anti-NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1997R)
Ask
View Details 
MBS6197734-01 0.1 mL
RUNX2 (Runt-Related Transcription Factor 2, AML3, CBFA1, CCD, CCD1, MGC120022, MGC120023, OSF2, PEA2aA, PEBP2A1, PEBP2A2, PEBP2aA, PEBP2aA1) (MaxLight 405)
Ask
View Details MBS6197734-02 5x 0.1 mL
RUNX2 (Runt-Related Transcription Factor 2, AML3, CBFA1, CCD, CCD1, MGC120022, MGC120023, OSF2, PEA2aA, PEBP2A1, PEBP2A2, PEBP2aA, PEBP2aA1) (MaxLight 405)
Ask
View Details 
MBS1612271-01 96 Well
Mouse Tissue Factor Pathway Inhibitor, Tfpi Primacu ELISA Kit
Ask
View Details